Ignite Creation Date:
2024-05-06 @ 7:51 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02610777
Status:
COMPLETED
Last Update Posted:
2022-09-19
First Post:
2015-11-18
Brief Title:
An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes HR MDS Chronic Myelomonocytic Leukemia CMML and Low-Blast Acute Myelogenous Leukemia AML
Sponsor:
Millennium Pharmaceuticals Inc
Organization:
Takeda
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-18
First Submit QC Date:
November 19 2015
Study First Post Date:
2015-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-09-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-24
Last Update Post Date:
2022-09-19
Last Update Post Date Type:
ACTUAL